Ilika plc Launch Solid-state batteries enabling miniaturisation in MedTech

Ilika Plc

Ilika plc (LON: IKA), a pioneer in solid-state battery technology, announced today the launch of Stereax® M50 mm-scale solid-state batteries designed for medical implants. The Stereax M50 takes solid-state batteries to a new level of miniaturisation enabling medical device innovations that have previously been limited by the available battery technology.

Mike Nagy, Chief Technology Officer of Endotronix, which develops Hemodynamic Monitoring Solutions where Ilika’s technology could be applied, said:

“The implantable medical device industry has a growing need for miniaturised, long-life power sources to enable wireless data transfer from increasingly sophisticated devices that are improving patients’ lives.”

The ‘MedTech’ space is one of the most challenging environments for battery technologies. Batteries need to be small enough to be unobtrusive, enabling implantable devices to be charged in a way that does not restrict a patient, and have a long a life-span as possible, avoiding the risks associated with repeated surgical procedures. They also need to be biocompatible so that they do not pose a risk to the patient. Each device application may require different capacities and form factors, which can now be accommodated with the customisable battery sizes and shapes enabled by the Stereax M50. Innovation in applications that require injection into the blood stream, monitoring heart rhythm or attachment onto the peripheral nervous system for neurostimulation can be enabled with this technology. These batteries enable self-sustaining power sources that do not need to be changed regularly or use inconvenient cabling.

Relative to standard lithium ion batteries, Stereax M50 solid-state batteries have longer life spans of up to 10 years (up to 5x longer) and lower leakage currents (10x smaller), making them suitable for low power wireless charging. They can also be integrated with other electronic components enabling the end medical device to be kept as small as possible. Stereax M50 yields leading edge energy density with 50% extra density compared to other commercially available solid-state batteries.

Graeme Purdy, CEO, Ilika plc said:

“The Stereax product family continues to grow, addressing a wide range of end applications. Medical applications are some of the most demanding environments for battery technology. The Stereax M50 is a smaller, safer and longer lasting battery, opening up the opportunities of life enhancing medical devices.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Defence demand puts specialist battery technology in focus

Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions.

Battery & Energy Storage Tech Europe 2026 targets the next phase of industrial growth

Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market.

Ilika moves Goliath cells into independent commercial testing

Ilika has moved its UK-made Goliath cells into independent testing as it targets commercial opportunities in automotive, defence and e-bike markets.

Search